Access to neonatal metabolic screening in rural areas of Santo Domingo de los Tsáchilas-Alluriquín, Ecuador [ Acceso al tamizaje metabólico neonatal en áreas rurales de Santo Domingo de los Tsáchilas-Alluriquín, Ecuador]
DOI:
https://doi.org/10.62574/0tc5v853Keywords:
metabolism, jaundice neonatal, infant newbornAbstract
Objective: to analyse access to neonatal metabolic screening in rural areas of Santo Domingo de los Tsáchilas, Ecuador. Method: descriptive observational study of 51 newborns who underwent neonatal metabolic screening in 2023. Results: Economic limitations, reported by 21.7% of families, highlight the need to implement specific measures to guarantee equitable access to neonatal metabolic screening. Similarly, restricted access to medical services in rural areas (52.2%) and geographical and transport barriers (56.5%) indicate the importance of strengthening healthcare infrastructure and improving accessibility. Conclusion: Access to neonatal metabolic screening in rural areas such as Alluriquín, Santo Domingo de los Tsáchilas, is limited by economic, geographical, cultural and communication barriers, compromising the coverage and effectiveness of this essential service.
Downloads
References
Pappas KB. Newborn Screening. Pediatr Clin North Am. 2023;70(5):1013-1027. doi:10.1016/j.pcl.2023.06.003
Badiu Tișa I, Achim AC, Cozma-Petruț A. The Importance of Neonatal Screening for Galactosemia. Nutrients. 2022;15(1):10. Published 2022 Dec 20. doi:10.3390/nu15010010
Succoio M, Sacchettini R, Rossi A, Parenti G, Ruoppolo M. Galactosemia: Biochemistry, Molecular Genetics, Newborn Screening, and Treatment. Biomolecules. 2022;12(7):968. Published 2022 Jul 11. doi:10.3390/biom12070968
Schwartz O, Vill K, Pfaffenlehner M, et al. Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial. JAMA Pediatr. 2024;178(6):540-547. doi:10.1001/jamapediatrics.2024.0492
Chen T, Fan C, Huang Y, et al. Genomic Sequencing as a First-Tier Screening Test and Outcomes of Newborn Screening. JAMA Netw Open. 2023;6(9):e2331162. Published 2023 Sep 5. doi:10.1001/jamanetworkopen.2023.31162
Huang X, Wu D, Zhu L, et al. Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates. Orphanet J Rare Dis. 2022;17(1):66. Published 2022 Feb 21. doi:10.1186/s13023-022-02231-x
Adhikari AN, Gallagher RC, Wang Y, et al. The role of exome sequencing in newborn screening for inborn errors of metabolism. Nat Med. 2020;26(9):1392-1397. doi:10.1038/s41591-020-0966-5
López Galera RM, Castiñeiras Ramos D, Rocha H. Cribado neonatal del hipotiroidismo congénito [Neonatal screening for congenital hypothyroidism.]. Rev Esp Salud Publica. 2021;95:e202101010. Published 2021 Jan 26.
Mütze U, Kölker S. Evaluierung und Optimierung des Neugeborenenscreenings mittels strukturierter Langzeitbeobachtung – am Beispiel der angeborenen Stoffwechselerkrankungen [Evaluation and optimization of newborn screening by structured long-term follow-up-using the example of inherited metabolic diseases]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023;66(11):1249-1258. doi:10.1007/s00103-023-03772-7
Spiekerkoetter U, Bick D, Scott R, et al. Genomic newborn screening: Are we entering a new era of screening?. J Inherit Metab Dis. 2023;46(5):778-795. doi:10.1002/jimd.12650
Lak R, Yazdizadeh B, Davari M, Nouhi M, Kelishadi R. Newborn screening for galactosaemia. Cochrane Database Syst Rev. 2020;6(6):CD012272. Published 2020 Jun 22. doi:10.1002/14651858.CD012272.pub3
Zhao Z, Chen C, Sun X, Zhou D, Huang X, Dong H. Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: Outcome and cost-utility analysis. J Med Screen. 2022;29(1):12-20. doi:10.1177/09691413211021621
Men S, Liu S, Zheng Q, et al. Incidence and genetic variants of inborn errors of metabolism identified through newborn screening: A 7-year study in eastern coastal areas of China. Mol Genet Genomic Med. 2023;11(6):e2152. doi:10.1002/mgg3.2152
Bick SL, Nathan A, Park H, Green RC, Wojcik MH, Gold NB. Estimating the sensitivity of genomic newborn screening for treatable inherited metabolic disorders. Genet Med. 2025;27(1):101284. doi:10.1016/j.gim.2024.101284
Morava E, Baumgartner M, Patterson M, Peters V, Rahman S. Newborn screening: To WES or not to WES, that is the question. J Inherit Metab Dis. 2020;43(5):904-905. doi:10.1002/jimd.12303
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Copyright (c) 2024 By the authors. This article is open access and distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) licence (https://creativecommons.org/licenses/by-nc-sa/4.0/).
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
